Randomized Phase II Trial of Concomitant Chemoradiotherapy Using Weekly Carboplatin or Daily Low-Dose Cisplatin for Squamous Cell Carcinoma of the Head and Neck - Concepedia

Concepedia

Publication | Closed Access

Randomized Phase II Trial of Concomitant Chemoradiotherapy Using Weekly Carboplatin or Daily Low-Dose Cisplatin for Squamous Cell Carcinoma of the Head and Neck

51

Citations

9

References

2004

Year

Akihiro Homma, Hiroki Shirato, Yasushi Furuta, Takeshi Nishioka, Nobuhiko Oridate, Kazuhiko Tsuchiya, Tatsumi Nagahashi, Hidefumi Aoyama, Yukio Inuyama, Satoshi Fukuda

The Cancer Journal

Abstract

These findings suggest that weekly carboplatin treatment is preferable to daily low-dose cisplatin. This could be because the total dose of cisplatin was too low to be effective.

References

	Year	Citations

Page 1